Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lannett Co's share price for the quarter that ended in Mar. 2023 was $1.74. Lannett Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 10.8 Mil. Therefore, Lannett Co's market cap for the quarter that ended in Mar. 2023 was $18.8 Mil.
Lannett Co's quarterly market cap
increased
from Sep. 2022 ($18.5 Mil) to Dec. 2022 ($21.5 Mil) but then
declined
from Dec. 2022 ($21.5 Mil) to Mar. 2023 ($18.8 Mil).
Lannett Co's annual market cap
declined
from Jun. 2020 ($281.7 Mil) to Jun. 2021 ($184.8 Mil) and
declined
from Jun. 2021 ($184.8 Mil) to Jun. 2022 ($23.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lannett Co's Enterprise Value for Today is $593.4 Mil.
Lannett Co Market Cap Historical Data
The historical data trend for Lannett Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lannett Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lannett Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lannett Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Lannett Co's Market Cap falls into.
Lannett Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Lannett Co's Market Cap for the fiscal year that ended in Jun. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lannett Co (OTCPK:LCINQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Lannett Co Market Cap Related Terms
Thank you for viewing the detailed overview of Lannett Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LCINQ has been successfully added to your 